|
NNC0487-0111 Clinical Trials
9 actively recruiting trials across 8 locations
▲ +1 trial since June 2026
Pipeline
Phase 1: 1Phase 3: 8
Top Sponsors
- Novo Nordisk A/S9
Indications
- Obesity8
- Weight Loss7
- Overweight4
- Obstructive Sleep Apnoea2
- Diabetes Mellitus2
Other1 trial
Alexander City, Alabama1 trial
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Advanced Cardiovascular, LLC
Phase 3
Anniston, Alabama1 trial
Birmingham, Alabama1 trial
Gilbert, Arizona1 trial
Phoenix, Arizona1 trial
Escondido, California1 trial
San Diego, California1 trial
Miramar, Florida1 trial
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
South Broward Research LLC
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.